HB STRATEGIES (FKA HUSCH BLACKWELL STRATEGIES)

Lobbying for BAYER U.S. LLC · Pharmaceutical and life sciences company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $120,000.00 income · posted Jul 18, 2026

Lobbying activity 3

Health Issues

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Agriculture

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Pharmacy

Provide lobbying support on key issues and track relevant federal policy developments that could impact the pharmaceutical, healthcare industries generally and Bayer specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.